Skip to main content
Radiology Case Reports logoLink to Radiology Case Reports
. 2024 Oct 23;20(1):239–242. doi: 10.1016/j.radcr.2024.10.037

A rare case of a breast hamartoma containing a lesion with malignant presentation on radiologic evaluation and benign presentation on pathologic findings: A case report

Kiarash Soltani a, Mahdi Taghdiri b, Elham Keshavarz c,, Saloomeh Mohammadi d
PMCID: PMC11539359  PMID: 39507432

Abstract

Mammary hamartomas are rare, benign, and often under-diagnosed breast lesions comprised of glandular, adipose, muscular, and fibrotic encapsulated components which occur more commonly among perimenopausal women. The term hamartoma was initially coined by Arrigoni in 1971 to describe breast lesions with clinical resemblance to fibroadenomas. The proper diagnosis of breast hamartoma is confirmed through using multiple radiologic and pathologic modalities. Hamartomas rarely progress into malignancy with only a few cases reported in the literature. Here, we report a case of a highly suspicious lesion developing within a breast hamartoma in a 46-year-old woman with radiologic features of a malignant lesion with benign pathology.

Keywords: Breast, Hamartoma, Invasive carcinoma, BIRADS

Introduction

Breast hamartomas are rare, benign, and encapsulated lesions of unknown cause and pathogenesis [1,2]. These lesions may be comprised of glandular, adipose, muscular, and fibrotic tissue often with heterogenous tissue distribution [3,4]. Hamartomas rarely progress into malignant tissue, mainly due to similar composition to normal breast tissue [2]. With an overall low prevalence and female predominance, these lesions are being more frequently diagnosed mainly due to widespread breast cancer screening programs [5]. Notably, hamartomas can often be misdiagnosed as fibroadenoma which means that their prevalence may actually be higher [6,7]. The proper diagnosis of breast hamartoma is confirmed through using multiple diagnostic radiologic and pathologic modalities such as mammography, ultrasonography, magnetic resonance imaging, fine-needle aspiration biopsy, and core biopsy [2,8,9]. It is worth mentioning that due to lack of distinctive cytological and histological features, clinical diagnosis of hamartomas requires a multimodal approach [2]. Surgical excision is the treatment of choice in the majority of the hamartoma cases [10,11]. Herein, we report a rare case of a breast hamartoma containing a highly suspicious mass with pathologic and radiologic discordancy.

Case presentation

A 46-year-old woman was referred to Mahdiyeh hospital, a university-affiliated hospital located in Tehran, Iran in August 2024 concerning the follow-up of a mass located in the left breast of the patient. The patient claimed that the mass has been present there for many years and cannot remember the exact time when she was first aware of the mass. Family history was unremarkable. No history of Tabacco use was reported by the patient. Physical examination revealed a painless, soft, mobile, and palpable mass in the outer (lateral) part of the left breast.

Bilateral mammography showed an oval shaped circumscribed predominantly fatty mass measuring about 9.5 × 7.5 × 8 cm in the upper outer quadrant of the left breast (Fig. 1A, and B). In addition, a hyperdense mass measuring approximately 4.5 × 4 × 3 cm with irregular shape and spiculated margins associated with coarse heterogenous microcalcifications was seen within the mentioned lesion (Fig. 1C). BI-RADS V score as given.

Fig. 1.

Fig 1

(A and B) Mediolateral Oblique (MLO) View and Craniocaudal (CC) View mammograms of left breast. An oval circumscribed, predominantly fatty mass in the left breast Upper Outer Quadrant (UOQ). (C) magnified view of the lesion indicates a hyperdense mass with irregular shape and spiculated margin associated with coarse heterogeneous microcalcifications within it.

Due to the unusual presentation of the mass and its relatively large size, magnetic resonance imaging (MRI) evaluation was ordered. MRI evaluation confirmed the presence of an oval shaped circumscribed mass of predominant internal adipose intensity (nonenhancing) containing an internal irregular spiculated mass of heterogenous T2 hypo-intensity with heterogenous enhancement and medium/plateau kinetics (Fig. 2). BI-RADS V score was again confirmed.

Fig. 2.

Fig 2

(A) Axial Turbo inversion recovery magnitude (TIRM), (B) Axial T1 fast spin echo, (C) Axial subtraction post contrast phase. An oval circumscribed mass of predominant internal fat intensity with an internal irregular spiculated mass of heterogenous T2 hypo intensity, heterogenous enhancement and medium/plateau kinetics.

Upon pathologic evaluation, ultrasound-guided core needle biopsy was obtained from the irregular mass with revealed a benign mass comprised of ducts, lobules, and adipose tissue with disorganized structure (Fig. 3).

Fig. 3.

Fig 3

(A) Histopathologic view of the ultrasound guided biopsy specimen. Lobules and ducts of the mammary gland, and fibrous stroma and adipose tissue are located in a disorganized structure. Glands appear structurally normal with little proliferation. Neither cytoarchitectural atypia, nor significant mitosis is observed. (B) a view of invasive ductal carcinoma showing tumor clusters with focal tubule formation with desmoplastic stroma (the picture is for comparison and is not related to our patient). In contrast, invasive ductal carcinoma mostly has irregular borders and is comprised of atypical cells forming ducts and sheets with an infiltrative pattern in a desmoplastic stroma. Nuclear pleomorphism is evident, necrosis, and mitosis are also have been observed.

Due to the discordancy in radiologic and pathologic findings, and after the case was discussed in our multidisciplinary team, the patient underwent surgery and left breast mass was excised. On gross examination, the mass appears as a benign, well-circumscribed breast tumor composed of randomly arranged and well-differentiated glandular and stromal mammary structures, and also adipose tissue and smooth muscles (Fig. 4). The histologic evaluation of lobules and ducts within the adipose tissue was normal. The microscopic evaluation of the excised mass also revealed that lobules and ducts of the mammary gland, and fibrous stroma and adipose tissue are placed in a disorganized structure. Mammary glands appear structurally normal with little proliferation. Based on our evaluations, the patient had normal glands and lobules, and also neither cytoarchitectural atypia, nor significant mitosis were observed. Histopathologic findings also confirmed the core biopsy results.

Fig. 4.

Fig 4

(A) Postsurgical resection specimen (Gross pathology), (B) inside the resected tumor was yellow and white with areas of fat and calcifications, (C) mammographic view of the resected tumor.

Discussion

Hamartomas are well-circumscribed, benign, and slow-growing masses containing varying degrees of fibrous tissue, adipose tissue, glandular tissue, and to some extent muscular tissue [1,12]. The average size of hamartomas is approximately 2-5 cm in diameter, however larger sizes have also been reported [13]. These lesions are rarely detected among men and usually occur in middle-aged, perimenopausal women accounting for less than 1 percent of all benign breast lesions [5,14].

Histologically, these lesions are composed of acinar units, arranged in a lobular pattern within a hyalinized, fibrous stroma and contain variable amounts of fat content in the interlobular regions [15,16].

The characteristic mammographic appearance of a hamartoma consists of a circumscribed mass with a thin pseudo capsule and a mix of fatty and soft-tissue elements [17]. The mammographic density of the mass can vary depending on the fat—parenchyma ratio. Although lesion with high fat content can mimic a lipoma, lesions with a predominance of glandular or fibrous tissues may be confused with other solid masses [[18], [19], [20]].

On MRI evaluation, T1- and T2-weighted sequences, the mass generally exhibits heterogeneous signal intensity, reflecting the presence of glandular and adipose tissue components contained within a thin capsule. After administration of contrast medium, hamartomas show a gradual, progressive enhancement with a type I time/intensity curve. By providing a cross-sectional view of the lesion, breast MRI is considered a more advantageous imaging technique compared to mammography or ultrasound in confirming the diagnosis of hamartoma [[20], [21], [22], [23]]. Hamartomas are challenging to diagnose, therefore, the use of a variety of breast screening modalities is warranted such as biopsy and different imaging techniques.

On gross examination, hamartomas are well-defined masses with smooth glistening surfaces when cut. Microscopically, they are composed of a combination of epithelial and stromal elements, usually with normal ducts or lobules, although variations of normal tissue may also be present [[24], [25], [26]].

Breast hamartomas are not considered premalignant lesions and are generally a benign lesion with rare presentation of malignancy. The probability of normal breast tissue within hamartoma to undergo malignant changes is as low as 0.1%. It is important to note that cases of carcinoma with benign histology have been reported within or adjacent to hamartomas and the possibility of malignancy should not be neglected [2,24,[27], [28], [29]].

In conclusion, we report a rare case of hamartoma in which different radiologic findings were in favor of a highly malignant tissue growing within the hamartoma. Subsequent evaluations revealed otherwise, and malignancy was ruled out. We believe that this presentation is extremely rare and given the low number of previous case reports regarding hamartomas our case is interesting to be examined.

Patient consent

Written informed consent has been obtained from the patient in Persian (the patient's native language). Upon request, we will send it to the respected journal.

Footnotes

Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  • 1.Herbert M, Sandbank J, Liokumovich P, Yanai O, Pappo I, Karni T, Segal M. Breast hamartomas: clinicopathological and immunohistochemical studies of 24 cases. Histopathology. 2002;41(1):30–34. doi: 10.1046/j.1365-2559.2002.01429.x. [DOI] [PubMed] [Google Scholar]
  • 2.Tazeoğlu D, Dağ A, Arslan B, Berkeşoğlu M. Breast hamartoma: clinical, radiological, and histopathological evaluation. European Journal of Breast Health. 2021;17(4):328. doi: 10.4274/ejbh.galenos.2021.2021-3-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Alran L, Chamming's F, Auriol-Leizagoyen S, Velasco V, Deleau F, Brouste V, et al. Breast hamartoma: reassessment of an under-recognised breast lesion. Histopathology. 2022;80(2):304–313. doi: 10.1111/his.14544. [DOI] [PubMed] [Google Scholar]
  • 4.Amir R, Sheikh S. Breast hamartoma: a report of 14 cases of an under-recognized and under-reported entity. International journal of surgery case reports. 2016;22:1–4. doi: 10.1016/j.ijscr.2016.03.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wang Z, He J. Giant breast hamartoma in a 41‑year‑old female: A case report and literature review. Oncology Letters. 2015;10(6):3719–3721. doi: 10.3892/ol.2015.3794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Page DL, Anderson TJ. Diagnostic histopathology of the breast. (No Title). 1987.
  • 7.Ghaedi Y, Howlett D. Giant left breast hamartoma in a 45-year-old woman. Case Reports. 2018;2018 doi: 10.1136/bcr-2018-226012. bcr-2018-226012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Sonmez FC, Gucin Z, Yildiz P, Tosuner Z. Hamartoma of the breast in two patients: A case report. Oncology letters. 2013;6(2):442–444. doi: 10.3892/ol.2013.1366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Weinzweig N, Botts J, Marcus E. Giant hamartoma of the breast. Plastic and reconstructive surgery. 2001;107(5):1216–1220. doi: 10.1097/00006534-200104150-00019. [DOI] [PubMed] [Google Scholar]
  • 10.Guray M, Sahin AA. Benign breast diseases: classification, diagnosis, and management. The oncologist. 2006;11(5):435–449. doi: 10.1634/theoncologist.11-5-435. [DOI] [PubMed] [Google Scholar]
  • 11.Ngeow J, Sesock K, Eng C. Breast cancer risk and clinical implications for germline PTEN mutation carriers. Breast cancer research and treatment. 2017;165:1–8. doi: 10.1007/s10549-015-3665-z. [DOI] [PubMed] [Google Scholar]
  • 12.Magro G, Bisceglial M. Muscular hamartoma of the breast. Case report and review of the literature. Pathology-Research and Practice. 1998;194(5):349–355. doi: 10.1016/s0344-0338(98)80059-9. [DOI] [PubMed] [Google Scholar]
  • 13.Sanal HT, Ersoz N, Altinel O, Unal E, Can C. Giant hamartoma of the breast. Breast Journal. 2006;12(1):84–85. doi: 10.1111/j.1075-122X.2006.00193.x. [DOI] [PubMed] [Google Scholar]
  • 14.Ravakhah K, Javadi N, Simms R. Hamartoma of the breast in a man: first case report. The Breast Journal. 2001;7(4):266–268. doi: 10.1046/j.1524-4741.2001.20079.x. [DOI] [PubMed] [Google Scholar]
  • 15.Arrigoni M, Dockerty M, Judd E. The identification and treatment of mammary hamartoma. Surgery, gynecology & obstetrics. 1971;133(4):577–582. [PubMed] [Google Scholar]
  • 16.Riveros M, Cubilla A, Perotta F, Solalinde V. Hamartoma of the breast. Journal of surgical oncology. 1989;42(3):197–200. doi: 10.1002/jso.2930420314. [DOI] [PubMed] [Google Scholar]
  • 17.Helvie MA, Adler DD, Rebner M, Oberman HA. Breast hamartomas: variable mammographic appearance. Radiology. 1989;170(2):417–421. doi: 10.1148/radiology.170.2.2911664. [DOI] [PubMed] [Google Scholar]
  • 18.Mendiola H, Henrik-Nielsen R, Dyreborg U, Blichert-Toft M, Al-Hariri J. Lobular Carcinoma in Situ Occurring in Adenolipoma of the Breast: Report of a Case. Acta Radiologica Diagnosis. 1982;23(5):503–505. doi: 10.1177/028418518202300511. [DOI] [PubMed] [Google Scholar]
  • 19.Farrokh D, Hashemi J, Ansaripour E. Breast hamartoma: mammographic findings. Iranian Journal of Radiology. 2011;8(4):258. doi: 10.5812/iranjradiol.4492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Presazzi A, Di Giulio G, Calliada F. Breast hamartoma: ultrasound, elastosonographic, and mammographic features. Mini pictorial essay. Journal of ultrasound. 2015;18:373–377. doi: 10.1007/s40477-015-0175-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Erdem G, Karakas HM, Isik B, Firat AK. Advanced MRI findings in patients with breast hamartomas. Diagnostic and Interventional Radiology. 2011;17(1):33. doi: 10.4261/1305-3825.DIR.1892-08.2. [DOI] [PubMed] [Google Scholar]
  • 22.Tse G, Law B, Ma T, Chan A, Pang L, Chu W, Cheung H. Hamartoma of the breast: a clinicopathological review. Journal of clinical pathology. 2002;55(12):951–954. doi: 10.1136/jcp.55.12.951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Cucci E, Santoro A, Di Gesú C, Ciuffreda M, Maselli G, Pierro A, Sallustio G. Integrated imaging of breast hamartoma: two case reports. Breast Disease. 2015;35(1):53–57. doi: 10.3233/BD-140379. [DOI] [PubMed] [Google Scholar]
  • 24.da Silva BB, Rodrigues JS, Borges US, Pires CG, da Silva RFP. Large mammary hamartoma of axillary supernumerary breast tissue. The Breast. 2006;15(1):135–136. doi: 10.1016/j.breast.2005.03.004. [DOI] [PubMed] [Google Scholar]
  • 25.Fisher C, Hanby A, Robinson L, Millis R. Mammary hamartoma—a review of 35 cases. Histopathology. 1992;20(2):99–106. doi: 10.1111/j.1365-2559.1992.tb00938.x. [DOI] [PubMed] [Google Scholar]
  • 26.D'Orsi CJ, Feldhaus L, Sonnenfeld M. Unusual lesions of the breast. Radiologic Clinics of North America. 1983;21(1):67–80. [PubMed] [Google Scholar]
  • 27.Scally N, Campbell W, Hall S, McCusker G, Stirling W. Invasive ductal carcinoma arising within a breast hamartoma. Irish journal of medical science. 2011;180:767–768. doi: 10.1007/s11845-009-0402-9. [DOI] [PubMed] [Google Scholar]
  • 28.Ruiz-Tovar J, Reguero-Callejas ME, Aláez AB, Ramiro C, Rojo R, Collado MV, et al. Infiltrating ductal carcinoma and ductal carcinoma in situ associated with mammary hamartoma. The Breast Journal. 2006;12(4):368–370. doi: 10.1111/j.1075-122X.2006.00279.x. [DOI] [PubMed] [Google Scholar]
  • 29.Baron M, Ladonne JM, Gravier A, Picquenot JM, Berry M. Invasive lobular carcinoma in a breast hamartoma. The Breast Journal. 2003;9(3):246–248. doi: 10.1046/j.1524-4741.2003.09313.x. [DOI] [PubMed] [Google Scholar]

Articles from Radiology Case Reports are provided here courtesy of Elsevier

RESOURCES